Asked by: Robert Largan (Conservative - High Peak)
Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, when he plans to respond to the enquiry from the hon. Member for High Peak dated 12 January 2021, referenced RL16885.
Answered by Amanda Solloway
My hon Friend the Minister for Small Business, Consumers and Labour Markets replied to my hon Friend on 2nd June 2021.
Asked by: Robert Largan (Conservative - High Peak)
Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, when he plans to respond to the enquiry from the hon. Member for High Peak dated 27 January 2021, referenced RL17479.
Answered by Amanda Solloway
My Hon Friend the Minister of State for Business, Energy and Clean Growth replied to my hon Friend on 2 June 2021.
Asked by: Robert Largan (Conservative - High Peak)
Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, when he plans to respond to the letter of 17 December 2020 from the hon. Member for High Peak, reference RL16182.
Answered by Amanda Solloway
I confirm that the Department received my hon Friend’s correspondence on 17th December (reference RL16182). A response was issued on 7th January, signed by my noble Friend, Lord Callanan. A copy of the response has been reissued.
Asked by: Robert Largan (Conservative - High Peak)
Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, when he plans to respond to the enquiry of 9 February 2021 from the hon. Member for High Peak with the reference RL19001.
Answered by Amanda Solloway
It has not proved possible to respond to my Hon. Friend in the time available before Prorogation.
Asked by: Robert Largan (Conservative - High Peak)
Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he is taking to support domestic pharmaceutical manufacturing capacity during the covid-19 outbreak.
Answered by Amanda Solloway
The Government continues to strongly support the vision set out in the Life Sciences Industrial Strategy to make the UK a top tier global hub for biomedical and clinical research, and medical innovation.
We recognise the importance of life sciences and medicines supply during this pandemic and the Governments recognition of this group as being key workers has ensured pharmaceutical manufacturing has continued throughout the outbreak. The Government is determined to protect lives and protect livelihoods.
Vaccine and therapeutics for Covid-19 are moving rapidly through clinical trials. Government is working closely with industry to assess UK manufacturing capability for a range of potential new vaccines. The type of capacity and the specific groups needed to take this further will be determined by the technology used to produce the vaccines and the type of vaccine produced.
We have also announced a further £93 million to accelerate the building of the new Vaccines Manufacturing and Innovation Centre so it can open in summer 2021, a year ahead of schedule.
While the centre is being built, the Government will establish a rapid deployment facility thanks to a further investment of £38m to begin manufacturing at scale from this summer.
Asked by: Robert Largan (Conservative - High Peak)
Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, what role the Government plans for the NHS to play as a delivery partner in the UK’s Industrial Strategy.
Answered by Nadhim Zahawi
The NHS is an integral part of the UK’s Industrial Strategy and is a key partner for the life sciences industry. The two Life Sciences Sector Deals detail the strong partnerships between the Government, industry, universities, and charities, and demonstrate the pivotal role of the NHS as a central delivery partner, which is reaffirmed by the NHS Long Term Plan.
The Government will continue to work with the NHS to build a stronger innovation ecosystem in the UK, including through an enhanced Accelerated Access Collaborative.